Carolyn Majcher, OD, FAAO; and Marc R. Bloomenstein, OD, FAAO
Show Description +
Carolyn Majcher, OD, FAAO, joins Marc R. Bloomenstein, OD, FAAO, to discuss the diagnosis and common risk factors of macular degeneration. She explains the limitations of traditional treatment options for geographic atrophy (GA) and highlights the advantages of two recently FDA-approved treatments to slow the progression of GA. She comments on the ideal patient candidates for each medication and shares advice on diagnosing or referring patients with GA.
Posted: 8/22/2023
Carolyn Majcher, OD, FAAO; and Marc R. Bloomenstein, OD, FAAO
Carolyn Majcher, OD, FAAO, joins Marc R. Bloomenstein, OD, FAAO, to discuss the diagnosis and common risk factors of macular degeneration. She explains the limitations of traditional treatment options for geographic atrophy (GA) and highlights the advantages of two recently FDA-approved treatments to slow the progression of GA. She comments on the ideal patient candidates for each medication and shares advice on diagnosing or referring patients with GA.
Posted: 8/22/2023
Please log in to leave a comment.